;

Articles Not Curated - Drug studies in humans
Last updated: 2025 May 18
Total hit(s): 8159
S.No.
1
40214651
From Wuhan to Omicron K.P2 strain: A comprehensive review of SARS-CoV-2 phylogeny and public health implications of the latest booster vaccine.
Hum Vaccin Immunother
2025 Dec
4.7
1
2
40195167
Safety profile of self-amplifying mRNA SARS-CoV-2 vaccine ARCT-154 in adults: a pooled phase 1/2/3 randomized clinical study.
Expert Rev Vaccines
2025 Dec
4.37
1
3
40051347
Limitations of neutralizing antibody titers in COVID-19 vaccine efficacy trials and a call for additional correlates of protection.
Hum Vaccin Immunother
2025 Dec
4.7
1
4
40329514
Integrating immune library probing with structure-based computational design to develop potent neutralizing nanobodies against emerging SARS-CoV-2 variants.
MAbs
2025 Dec
10
1
5
39887328
Willingness to pay for the effect of SARS-CoV-2 antivirals in preventing COVID-19 transmission to others in the Japanese population.
J Med Econ
2025 Dec
1
6
40371698
Natural product sennoside B disrupts liquid-liquid phase separation of SARS-CoV-2 nucleocapsid protein by inhibiting its RNA-binding activity.
J Enzyme Inhib Med Chem
2025 Dec
8.6
1
7
40366666
A four-week study on the toxicity of repeated intramuscular administration of plant-based BA-CoV2-0301 vaccine against SARS-CoV-2 in Sprague-Dawley rats.
J Immunotoxicol
2025 Dec
1
8
40028815
Impact of FcRn antagonism on vaccine-induced protective immune responses against viral challenge in COVID-19 and influenza mouse vaccination models.
Hum Vaccin Immunother
2025 Dec
4.7
1
9
40381203
Safety and immunogenicity of SARS-CoV-2 protein subunit recombinant vaccine (Indovac(R)) in healthy populations aged 18 years and above in Indonesia: A phase I, observer-blind, randomized, controlled study.
Hum Vaccin Immunother
2025 Dec
4.7
1
10
40214201
A One Health approach to bovine coronavirus vaccine development, using LSDV as a live virus vector.
Hum Vaccin Immunother
2025 Dec
4.7
1
11
40432512
Neutralizing antibody levels as a key factor in determining the immunogenic efficacy of the novel PEDV alpha coronavirus vaccine.
Vet Q
2025 Dec
8.5
1
12
40376714
Efficacy, immunogenicity, and safety of heterologous boosting with a novel chimera Chinese mRNA (RQ3013) SARS-CoV-2 vaccine: A randomized, double-blind, active-controlled trial.
Hum Vaccin Immunother
2025 Dec
4.7
1
13
40134119
Gaps in vaccine clinical trials in Africa: A mixed scoping review and bibliometric analysis before, during, and post- COVID-19 pandemic.
Hum Vaccin Immunother
2025 Dec
4.7
1
14
39834144
Sustained immunogenicity of bivalent protein COVID-19 vaccine SCTV01C against antigen matched and mismatched variants.
Expert Rev Vaccines
2025 Dec
4.37
1
15
39865693
Immunogenicity and safety of a COVID-19 DNA vaccine in healthy adults and elderly: A randomized, observer-blind, placebo-controlled phase 2 trial.
Hum Vaccin Immunother
2025 Dec
4.7
1
16
40077853
Characterization of the binding features between SARS-CoV-2 5'-proximal transcripts of genomic RNA and nucleocapsid proteins.
RNA Biol
2025 Dec
1
17
40045463
The characterization of technical design of a virus-like structure (VLS) nanodelivery system as vaccine candidate against SARS-CoV-2 variants.
Hum Vaccin Immunother
2025 Dec
4.7
1
18
39643949
Modeling the potential public health and economic impact of different COVID-19 vaccination strategies with an adapted vaccine in the Kingdom of Saudi Arabia.
Expert Rev Vaccines
2025 Dec
4.37
1
19
39720838
Immunogenicity and safety of SARS-CoV-2 recombinant protein vaccine (CHO cell) LYB001 as a heterologous booster following two- or three-dose inactivated COVID-19 vaccine in adults aged >/=18 years: interim results of a randomized, active-controlled, double-blinded, phase 3 trial.
Expert Rev Vaccines
2025 Dec
4.37
1
20
40288233
Evaluation of SARS-CoV-2 antibody detection methods for wild Cervidae.
Prev Vet Med
2025 Aug
2.33
1
21
40440921
Risk of Guillain-Barre syndrome after COVID-19 vaccination or SARS-CoV-2 infection: A multinational self-controlled case series study.
Vaccine
2025 Jul 11
3.31
1
22
40510179
The effect of dual inflammation on the acute phase clinical outcomes of schizophrenia patients with comorbid COVID-19.
Brain Behav Immun Health
2025 Jul
1
23
40419190
Successive SARS-CoV-2 mutations in a highly susceptible host: A case report of persistent viremia and fatality.
J Infect Chemother
2025 Jul
1.59
1
24
40436249
A nationwide epidemiological survey of coronavirus disease 2019-associated pulmonary aspergillosis in Japan.
J Infect Chemother
2025 Jul
1.59
1
25
40522253
Analysis of Hyperexpanded T Cell Clones in SARS-CoV-2 Vaccine-Associated Liver Injury by Spatial Proteomics and Transcriptomics.
Liver Int
2025 Jul
5.2
1